{"disease":{"id":"ataxia-telangiectasia","name":"ataxia telangiectasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04037189","title":"Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT04991701","title":"A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":178,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT07499999","title":"Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06193200","title":"Evaluate the Neurological Effects of EryDex on Subjects With A-T","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT03563053","title":"Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":104,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":true},{"nct_id":"NCT06664853","title":"Open-Label Extension of EryDex Study IEDAT-04-2022","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":101,"lead_sponsor_name":"Quince Therapeutics S.p.A.","has_results":false},{"nct_id":"NCT06673056","title":"A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"IntraBio Inc","has_results":false},{"nct_id":"NCT05531890","title":"Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Grace Therapeutics Inc.","has_results":false},{"nct_id":"NCT04605523","title":"Neurofilament Light- Chain in Ataxia Telangiectasia","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT05692622","title":"Home-based Complex Intervention for Children With Ataxia Telangiectasia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Plymouth","has_results":false},{"nct_id":"NCT05252819","title":"Whole Body MRI for Cancer Surveillance in A-T","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT03357978","title":"Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT04513002","title":"Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT02733679","title":"Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"NHS Tayside","has_results":false},{"nct_id":"NCT03962114","title":"Effects of Vitamin B3 in Patients With Ataxia Telangiectasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT02285348","title":"Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT03759678","title":"N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"IntraBio Inc","has_results":true},{"nct_id":"NCT04870866","title":"NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":13,"lead_sponsor_name":"University Hospital, Akershus","has_results":false},{"nct_id":"NCT06324877","title":"Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT02246491","title":"Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05471310","title":"Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","has_results":false},{"nct_id":"NCT07380165","title":"Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"IntraBio Inc","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}